The University of Chicago Header Logo

Connection

David Rubin to Multiple Sclerosis, Relapsing-Remitting

This is a "connection" page, showing publications David Rubin has written about Multiple Sclerosis, Relapsing-Remitting.
  1. Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis. Inflamm Bowel Dis. 2026 May 01; 32(5):954-962.
    View in: PubMed
    Score: 0.904
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.